Bertrand L. Chenard

1.0k citations

28 papers · 668 indexed · h-index 15

Cellular and Molecular Neuroscience top 10%
Molecular Biology
Organic Chemistry top 10%
Pharmacology
Sensory Systems top 10%

Co-authors: Frank S. Menniti John S. Swenton James E. Krause Daniel N. Cortright T. V. RajanBabu Michael A. Petti Martin J. Pagnozzi William F. White
Topics: Neuroscience and Neuropharmacology Research (10 papers)Bioactive Compounds and Antitumor Agents (6 papers)Oxidative Organic Chemistry Reactions (5 papers)
Cited by: Cellular and Molecular Neuroscience Sensory Systems Toxicology
Journals: Journal of the American Chemical Society Journal of Biological Chemistry Stroke
Partner nations: United States United Kingdom Canada

In The Last Decade

Bertrand L. Chenard

28 papers receiving 632 citations

Peers

Countries citing papers authored by Bertrand L. Chenard

Since Specialization

Citations

This map shows the geographic impact of Bertrand L. Chenard's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bertrand L. Chenard with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bertrand L. Chenard more than expected).

Fields of papers citing papers by Bertrand L. Chenard

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bertrand L. Chenard. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bertrand L. Chenard. The network helps show where Bertrand L. Chenard may publish in the future.

Co-authorship network of co-authors of Bertrand L. Chenard

This figure shows the co-authorship network connecting the top 25 collaborators of Bertrand L. Chenard. A scholar is included among the top collaborators of Bertrand L. Chenard based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bertrand L. Chenard. Bertrand L. Chenard is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Pyrido[2,3-b]pyrazines, discovery of TRPV1 antagonists with reduced potential for the formation of reactive metabolites 2010 ·Bioorganic & Medicinal Chemistry Letters ·Kevin J. Hodgetts,Charles A. Blum,Timothy M. Caldwell,Rajagopal Bakthavatchalam,Xiaozhang Zheng,(unknown),James E. Krause,Daniel N. Cortright,Marci Crandall,Beth Murphy,Susan Boyce,A. Brian Jones,Bertrand L. Chenard	10
2	C5a, But Not C3a, Increases VEGF Secretion in ARPE-19 Human Retinal Pigment Epithelial Cells 2009 ·Current Eye Research ·Daniel N. Cortright,Robin Meade,Stephen M. Waters,Bertrand L. Chenard,James E. Krause	41
3	Aminoquinazolines as TRPV1 antagonists: Modulation of drug-like properties through the exploration of 2-position substitution 2008 ·Bioorganic & Medicinal Chemistry Letters ·Charles A. Blum,Xiaozhang Zheng,Harry L. Brielmann,Kevin J. Hodgetts,Rajagopal Bakthavatchalam,Jayaraman Chandrasekhar,James E. Krause,Daniel N. Cortright,David J. Matson,Marci Crandall,(unknown),Lawrence K. Fung,(unknown),Mark T. Kershaw,Stéphane De Lombaert,Bertrand L. Chenard	13
4	Aminopyrazine CB1 receptor inverse agonists 2008 ·Bioorganic & Medicinal Chemistry Letters ·David J. Wustrow,George D. Maynard,Jun Yuan,He Zhao,Jian-min Mao,(unknown),Mark T. Kershaw,(unknown),Robbin Brodbeck,(unknown),Dan Zhou,(unknown),Bertrand L. Chenard,James E. Krause,Alan Hutchison	7
5	1-Benzylbenzimidazoles: The discovery of a novel series of bradykinin B1 receptor antagonists 2008 ·Bioorganic & Medicinal Chemistry Letters ·(unknown),Jayaraman Chandrasekhar,David C. Ihle,David J. Wustrow,Bertrand L. Chenard,James E. Krause,Alan Hutchison,(unknown),(unknown),Daniel N. Cortright,Daniel C. Broom,Mark T. Kershaw,(unknown),Yao Peng,Kevin J. Hodgetts	9
6	An Efficient Preparation of β-Aryl-β-ketophosphonates by the TFAA/H₃PO₄-Mediated Acylation of Arenes with Phosphonoacetic Acids 2008 ·The Journal of Organic Chemistry ·George P. Luke,(unknown),(unknown),Bertrand L. Chenard	14
7	Opportunities and Challenges in the Discovery of New Central Nervous System Drugs 2008 ·Annals of the New York Academy of Sciences ·James E. Krause,Bertrand L. Chenard	3
8	Development of a Scaleable Synthesis of NDT 9533750, a Key Intermediate to a Series of Novel Subtype Preferring GABA_A Partial Agonists 2007 ·Organic Process Research & Development ·(unknown),Bingsong Han,(unknown),(unknown),Bertrand L. Chenard,George Maynard,(unknown)	1
9	Molecular Characterization of the Gerbil C5a Receptor and Identification of a Transmembrane Domain V Amino Acid That Is Crucial for Small Molecule Antagonist Interaction 2005 ·Journal of Biological Chemistry ·Stephen M. Waters,Robbin Brodbeck,Jeremy Steflik,Jianying Yu,(unknown),(unknown),Daniel L. Severance,(unknown),Kevin Currie,Bertrand L. Chenard,Alan Hutchison,George Maynard,James E. Krause	22
10	Transient receptor potential ion channels as targets for the discovery of pain therapeutics. 2005 ·PubMed ·James E. Krause,Bertrand L. Chenard,Daniel N. Cortright	44
11	CP-465,022, a Selective Noncompetitive AMPA Receptor Antagonist, Blocks AMPA Receptors but Is Not Neuroprotective In Vivo 2003 ·Stroke ·Frank S. Menniti,Alastair M. Buchan,Bertrand L. Chenard,D.J. Critchett,Alan H. Ganong,Victor Guanowsky,Patricia A. Seymour,Willard M. Welch	24
12	Quinazolin-4-one α-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid (AMPA) Receptor Antagonists: Structure−Activity Relationship of the C-2 Side Chain Tether 2001 ·Journal of Medicinal Chemistry ·Bertrand L. Chenard,Willard M. Welch,James F. Blake,Todd W. Butler,(unknown),Frank E. Ewing,Frank S. Menniti,Martin J. Pagnozzi	37
13	CP-101,606, an NR2B subunit selective NMDA receptor antagonist, inhibits NMDA and injury induced c-fos expression and cortical spreading depression in rodents 2000 ·Neuropharmacology ·Frank S. Menniti,Martin J. Pagnozzi,Paul Butler,Bertrand L. Chenard,Sarah Jaw‐Tsai,William F. White	49
14	Characterization of the Binding Site for a Novel Class of Noncompetitive α-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid Receptor Antagonists 2000 ·Molecular Pharmacology ·Frank S. Menniti,Bertrand L. Chenard,Mary B. Collins,(unknown),Mark L. Elliott,Frank E. Ewing,Jianhua Huang,(unknown),John T. Lazzaro,Martin J. Pagnozzi,James L. Weeks,Willard M. Welch,William F. White	44
15	CP‐101,606: An NR2B‐Selective NMDA Receptor Antagonist 1998 ·CNS Drug Reviews ·Frank S. Menniti,Ajit Shah,Stephen A. Williams,Keith D. Wilner,William F. White,Bertrand L. Chenard	18
16	(3R,4S)-3-[4-(4-Fluorophenyl)-4-hydroxypiperidin-1-yl]chroman-4,7-diol: A Conformationally Restricted Analogue of the NR2B Subtype-Selective NMDA Antagonist (1S,2S)-1-(4-Hydroxyphenyl)-2- (4-hydroxy-4-phenylpiperidino)-1-propanol 1998 ·Journal of Medicinal Chemistry ·Todd W. Butler,James F. Blake,Jon Bordner,Paul Butler,Bertrand L. Chenard,Mary Collins,(unknown),(unknown),(unknown),Frank S. Menniti,Martin J. Pagnozzi,Steven B. Sands,(unknown),Walter A. Volberg,William F. White,Dayao Zhao	26
17	CP-101,606, a potent neuroprotectant selective for forebrain neurons 1997 ·European Journal of Pharmacology ·Frank S. Menniti,Bertrand L. Chenard,Mary Collins,(unknown),(unknown),(unknown)	92
18	Annelation reactions of quinone monoketals. Studies directed at an efficient synthesis of anthracyclinones 1984 ·The Journal of Organic Chemistry ·Bertrand L. Chenard,(unknown),Anthony D. Sercel,John S. Swenton	27
19	Synthesis and chemistry of 2-trimethylsilylbenzocyclobutenones 1981 ·Journal of the Chemical Society Chemical Communications ·Bertrand L. Chenard,Christopher A. Slapak,(unknown),John S. Swenton	10
20	A novel methoxy-directed ketal hydrolysis and its application to a convergent, regiospecific synthesis of (.+-.)-daunomycinone 1981 ·Journal of the American Chemical Society ·(unknown),Bertrand L. Chenard,John S. Swenton	28

About Bertrand L. Chenard

Bertrand L. Chenard is a scholar working on Toxicology, Sensory Systems and Cellular and Molecular Neuroscience, having authored 28 papers that have together received 668 indexed citations. Recurring topics across this work include Neuroscience and Neuropharmacology Research (10 papers), Bioactive Compounds and Antitumor Agents (6 papers) and Oxidative Organic Chemistry Reactions (5 papers). The work is most often cited by research in Cellular and Molecular Neuroscience (257 citations), Sensory Systems (55 citations) and Toxicology (33 citations). Bertrand L. Chenard has collaborated with scholars based in United States, United Kingdom and Canada. Frequent co-authors include Frank S. Menniti, John S. Swenton, James E. Krause, Daniel N. Cortright, T. V. RajanBabu, Michael A. Petti, Martin J. Pagnozzi, William F. White, Mary Collins and Willard M. Welch. Their work appears in journals such as Journal of the American Chemical Society, Journal of Biological Chemistry and Stroke.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact